Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
grade F 0.27 3.85% 0.01
JAGX closed up 3.85 percent on Friday, January 18, 2019, on 3.95 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JAGX trend table...

Date Alert Name Type % Chg
Jan 18 Shooting Star Candlestick Bearish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Crossed Above 20 DMA Bullish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Volume Surge Other 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Fell Below 20 DMA Bearish 3.85%
Jan 17 180 Bearish Setup Bearish Swing Setup 3.85%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.85%
Jan 17 Narrow Range Bar Range Contraction 3.85%

Older signals for JAGX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.
Is JAGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.6
52 Week Low 0.115
Average Volume 505,154
200-Day Moving Average 1.1323
50-Day Moving Average 0.3485
20-Day Moving Average 0.2637
10-Day Moving Average 0.2929
Average True Range 0.0434
ADX 20.02
+DI 23.9249
-DI 21.7169
Chandelier Exit (Long, 3 ATRs ) 0.2598
Chandelier Exit (Short, 3 ATRs ) 0.2452
Upper Bollinger Band 0.3609
Lower Bollinger Band 0.1665
Percent B (%b) 0.53
BandWidth 73.720137
MACD Line -0.0175
MACD Signal Line -0.0221
MACD Histogram 0.0046
Fundamentals Value
Market Cap 29.21 Million
Num Shares 108 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -1.73
Price-to-Sales 11.19
Price-to-Book 0.00
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.35
Resistance 3 (R3) 0.35 0.33 0.33
Resistance 2 (R2) 0.33 0.31 0.33 0.33
Resistance 1 (R1) 0.30 0.30 0.32 0.30 0.32
Pivot Point 0.28 0.28 0.29 0.28 0.28
Support 1 (S1) 0.25 0.26 0.27 0.25 0.22
Support 2 (S2) 0.23 0.25 0.23 0.21
Support 3 (S3) 0.20 0.23 0.21
Support 4 (S4) 0.20